Javascript must be enabled to continue!
The neuronal plasticity gene CRTC1 links survival with mitochondrial programs and tumor microenvironment features in Group 3 β medulloblastoma
View through CrossRef
Abstract
CREB-regulated transcription coactivator 1 (CRTC1) regulates neuronal development, plasticity, and activity-dependent transcription, but its role in medulloblastoma (MB) remains poorly understood. We investigated expression of the
CRTC1
gene during human cerebellar development and across pediatric brain tumors and examined its molecular and clinical associations in MB using public transcriptomic datasets.
CRTC1
was broadly expressed in the developing cerebellum, with cell-state-specific variation within the granule-cell lineage. Among pediatric brain tumors, MB showed the highest median
CRTC1
expression, which differed significantly among MB molecular groups and subtypes, with highest levels in Group 4 MB. High
CRTC1
expression was associated with longer overall survival specifically in Group 3 β MB and remained significant after correction across the 12 molecular subtypes. Within Group 3 β tumors,
CRTC1
expression was inversely associated with enrichment of mitochondrial and bioenergetic processes, including oxidative phosphorylation, mitochondrial organization, and mitochondrial translation, whereas
CRTC1
-high and
CRTC1
-low tumors displayed distinct transcriptional profiles.
CRTC1
was also associated with selected cell-type-related transcriptional signatures related to the tumor microenvironment. These findings identify
CRTC1
as a marker of biologically and clinically relevant transcriptional heterogeneity in Group 3 β MB and support further investigation of its functional and prognostic significance.
Graphical abstract
Title: The neuronal plasticity gene
CRTC1
links survival with mitochondrial programs and tumor microenvironment features in Group 3 β medulloblastoma
Description:
Abstract
CREB-regulated transcription coactivator 1 (CRTC1) regulates neuronal development, plasticity, and activity-dependent transcription, but its role in medulloblastoma (MB) remains poorly understood.
We investigated expression of the
CRTC1
gene during human cerebellar development and across pediatric brain tumors and examined its molecular and clinical associations in MB using public transcriptomic datasets.
CRTC1
was broadly expressed in the developing cerebellum, with cell-state-specific variation within the granule-cell lineage.
Among pediatric brain tumors, MB showed the highest median
CRTC1
expression, which differed significantly among MB molecular groups and subtypes, with highest levels in Group 4 MB.
High
CRTC1
expression was associated with longer overall survival specifically in Group 3 β MB and remained significant after correction across the 12 molecular subtypes.
Within Group 3 β tumors,
CRTC1
expression was inversely associated with enrichment of mitochondrial and bioenergetic processes, including oxidative phosphorylation, mitochondrial organization, and mitochondrial translation, whereas
CRTC1
-high and
CRTC1
-low tumors displayed distinct transcriptional profiles.
CRTC1
was also associated with selected cell-type-related transcriptional signatures related to the tumor microenvironment.
These findings identify
CRTC1
as a marker of biologically and clinically relevant transcriptional heterogeneity in Group 3 β MB and support further investigation of its functional and prognostic significance.
Graphical abstract.
Related Results
S-Nitrosylation of CRTC1 in Alzheimer’s disease impairs CREB-dependent gene expression induced by neuronal activity
S-Nitrosylation of CRTC1 in Alzheimer’s disease impairs CREB-dependent gene expression induced by neuronal activity
SUMMARY
CREB-regulated transcription coactivator 1 (CRTC1) plays an important role in synaptic plasticity, learning and long-term memory formatio...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Abstract 6505: Targeting PINK1 reduces medulloblastoma progression in animal models
Abstract 6505: Targeting PINK1 reduces medulloblastoma progression in animal models
Abstract
Medulloblastoma is a brain cancer that mainly arises during infancy and childhood. Medulloblastoma is the most common pediatric malignant brain tumor worldw...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract
Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract
Introduction
Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
<div>Abstract<p>Intratumor epigenetic heterogeneity is emerging as a key mechanism underlying tumor evolution and drug resistance. Epigenetic abnormalities frequently o...
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
<div>Abstract<p>Intratumor epigenetic heterogeneity is emerging as a key mechanism underlying tumor evolution and drug resistance. Epigenetic abnormalities frequently o...

